Ixaka
Roxana Tundrea currently works as a Senior Clinical Project Manager at Ixaka since October 2021. Previously, they worked as a Clinical Trials Manager at MorphoSys from January 2018 to September 2021.
Roxana Tundrea's education history begins in 2004 when they received a scholarship in English Linguistics from the University of Münster. This study opportunity lasted until 2005. In 2006, they enrolled at Ruhr University Bochum and completed their Master of Arts in English/American Studies in 2009. Roxana's educational journey continued at Berlin University of Applied Sciences Berlin (BHT) from 2010 to 2014, where they earned a Master of Science degree in Clinical Trials Management.
This person is not in any offices
Ixaka
1 followers
Ixaka is a private UK-based cell and gene therapy company with operations in the UK, Spain and France. The company is focused on the natural power of the body to cure disease. Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of disease and by directly modifying cells within the body to improve their therapeutic action. Ixaka’s technologies – concentrated multi-cell therapies and targeted nano-particles – demonstrate potential for the treatment of a broad range of serious diseases across oncology, cardiovascular, neurological and ocular diseases, and genetic disorders.